BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure
2020-01-01 Platini, ; Francesca, ; Ortolan, ; Elisa, ; Cavalieri, ; Stefano, ; Massa, ; Giacomo, ; Filippini, ; Daria, Maria; Alfieri, ; Salvatore, ; Bergamini, ; Cristiana, ; Resteghini, C; Orlandi, ; Ester, ; Paolini, ; Biagio, ; Piazza, ; Cesare, ; Perrone, ; Federica, ; Tamborini, ; Elena, ; Ferrarini, ; Linda, ; Serafini, ; Mara, Serena; Cappelletti, ; Vera, ; Daidone, ; Maria, Grazia; Licitra, ; Lisa, F.; Locati, ; Laura, Deborah
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area
2017-01-01 Cavallo, ; Cicchetti, ; Iacovelli, ; N., A.; Alessi, ; Padovano, ; Colombo, ; Facchinetti, ; Alfieri, ; Bossi, ; Resteghini, C; Licitra, ; Fallai, ; Crippa, ; Rancati, ; Pignoli, ; Orlandi,
Sinonasal non-glandular cancers relapsing after multimodal treatments
2017-01-01 Cavalieri, ; Granata, ; Locati, ; L., D.; Bergamini, ; Alfieri, ; Resteghini, C; Galbiati, ; Orlandi, ; Iacovelli, ; N., A.; Calareso, ; Guzzo, ; Quattrone, ; Licitra, ; Bossi,
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial
2022-01-01 Bossi, ; Paolo, ; Alberti, ; Andrea, ; Bergamini, ; Cristiana, ; Resteghini, C; Locati, ; Laura, Deborah; Alfieri, ; Salvatore, ; Cavalieri, ; Stefano, ; Colombo, ; Elena, ; Gurizzan, ; Cristina, ; Lorini, ; Luigi, ; Tovazzi, ; Valeria, ; Zamparini, ; Manuel, ; Ravanelli, ; Marco, ; Ascierto, ; Paolo, Antonio; Rampinelli, ; Vittorio, ; Grammatica, ; Alberto, ; Patuzzo, ; Roberto, ; Maurichi, ; Andrea, ; Licitra, ; Lisa, F.
Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration
2022-01-01 Trama, ; Matsuda, ; Charvat, ; Chiang, ; R. R., C-J.; Van, Gestel; A., J.; Martin, ; Geleijnse, ; Bonfarnuzzo, ; Licitra, ; L., F.; Cavalieri, ; Resteghini, C; Gatta, ; Botta,
A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer
2017-01-01 Cavalieri, ; Granata, ; Locati, ; Bergamini, ; Alfieri, ; Resteghini, C; Galbiati, ; Orlandi, ; Iacovelli, ; N., A.; Calareso, ; Guzzo, ; Quattrone, ; Licitra, ; Bossi,
An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients?
2016-01-01 Cassini, ; Alfieri, ; Bossi, ; Bergamini, ; Granata, ; Resteghini, C; Galbiati, ; Iacovelli, ; N., A.; Orlandi, ; Favales, ; Villa, ; Pistillo, ; Locati, ; Licitra,
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts)
2021-01-01 Bossi, ; Resteghini, C; Orlandi, ; Nicolai, ; Vischioni, ; Castelnuovo, ; Turri-Zanoni, ; Ferrari, ; Rampelli, ; Facchinetti, ; Gambazza, ; Calareso, ; Quattrone, ; Ingargiola, ; Cavallo, ; Franceschini, ; Tuzi, ; Mariani, ; Licitra, ; L., F.
A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era
2022-01-01 Bossi, ; Alberti, ; Zamparini, ; Orlandi, ; Grisanti, ; Trama, ; Resteghini, C; Nin, ; R., Mesia; Mohamad, ; Ozyar, ; Buglione, ; Airoldi, ; Vecchio, ; Livi, ; Cirauqui, ; B., Cirauqui; El-Sherify, ; Ursino, ; Argiris, ; Galiana, ; I., Linares; Licitra, ; L., F.
Druggable molecular targets in skin adnexal malignancies
2018-01-01 Cavalieri, ; Stefano, ; Perrone, ; Federica, ; Quattrone, ; Pasquale, ; Locati, ; Laura, ; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Alfieri, ; Salvatore, ; Resteghini, C; Galbiati, ; Donata, ; Platini, ; Francesca, ; Calareso, ; Giuseppina, ; Licitra, ; Lisa, F.; Bossi, ; Paolo,
Transcriptomic and tumor microenvironment landscape of EBV related nasopharyngeal carcinoma in endemic and non-endemic areas
2022-01-01 Licitra, ; L., F.; Serafini, ; Pistore, ; Canevari, ; Resteghini, C; Cavalieri, ; Trama, ; De, Cecco
Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies.
2019-01-01 Resteghini, C; Cavalieri, ; Stefano, ; Rametta, ; Alessandro, ; Alfieri, ; Salvatore, ; Galbiati, ; Donata, ; Platini, ; Francesca, ; Locati, ; Laura, Deborah; Bossi, ; Paolo, ; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Orlandi, ; Ester, ; Piazza, ; Cesare, ; Mancinelli, ; Moela, ; Licitra, ; Lisa, F.
Phase II study on lenvatinib (LEN) in recurrent and/or metastatic (R/M) adenoid cystic carcinomas (ACC) of the salivary glands (SG) of the upper aereodigestive tract (NCT02860936)
2018-01-01 Locati, ; Laura, ; Galbiati, ; Donata, ; Calareso, ; Giuseppina, ; Alfieri, ; Salvatore, ; Granata, ; Roberta, ; Bossi, ; Paolo, ; Bergamini, ; Cristiana, ; Resteghini, C; Cavalieri, ; Stefano, ; Platini, ; Francesca, ; Quattrone, ; Pasquale, ; Mancinelli, ; Moela, ; Zucchella, ; Andrea, ; Mariani, ; Luigi, ; Fedele, ; Guido, ; Licitra, ; Lisa, F.
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission
2021-01-01 Alfieri, ; Marceglia, ; Filippini, ; D., M.; Bergamini, ; Resteghini, C; Cavalieri, ; Peris, ; Sollena, ; Piccerillo, ; Gualdi, ; Ascierto, ; P., A.; Curvietto, ; Palla, ; De, Giorgi; Eibenschutz, ; Spagnolo, ; Orlandi, ; Locati, ; L., D.; Licitra, ; L., F.; Bossi,
Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract
2019-01-01 Locati, ; L., D.; Cavalieri, ; Bergamini, ; Resteghini, C; Alfieri, ; Calareso, ; Bossi, ; Quattrone, ; Granata, ; Galbiati, ; Platini, ; Orlandi, ; Mariani, ; Licitra,
Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience
2016-01-01 Alfieri, ; Bossi, ; Granata, ; Bergamini, C; Resteghini, C; Galbiati, ; Locati, ; Licitra,
Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer
2019-01-01 Bologna, ; Calareso, ; Resteghini, C; Sdao, ; Montin, ; Corino, ; Mainardi, ; Licitra, ; Bossi,
Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients
2020-01-01 Ivaldi, ; Infante, ; Facchinetti, ; Bossi, ; Iacovelli, ; N., A.; Cavallo, ; Ingargiola, ; Locati, ; L., D.; Bergamini, ; Resteghini, C; Licitra, ; Platini, ; Calareso, ; Fallai, ; Orlandi,
RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted?
2016-01-01 Resteghini, C; Alfieri, ; Quattrone, ; Dominoni, ; Garzone, ; Orlandi, ; Locati, ; Bergamini, ; Galbiati, ; Iacovelli, ; N., A.; Licitra, ; Bossi,
Relation between site of origin of monomorphic ventricular arrhythmias and myocardial tissue characteristics in non-ischemic left ventricular heart disease
2014-01-01 Nucifora, G; Muser, D; Masci, Pg; Barison, A; Piccoli, G; Rebellato, L; Facchin, D; Daleffe, E; Lombardi, M; Proclemer, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure | 1-gen-2020 | Platini, ; Francesca, ; Ortolan, ; Elisa, ; Cavalieri, ; Stefano, ; Massa, ; Giacomo, ; Filippini, ; Daria, Maria; Alfieri, ; Salvatore, ; Bergamini, ; Cristiana, ; Resteghini, C; Orlandi, ; Ester, ; Paolini, ; Biagio, ; Piazza, ; Cesare, ; Perrone, ; Federica, ; Tamborini, ; Elena, ; Ferrarini, ; Linda, ; Serafini, ; Mara, Serena; Cappelletti, ; Vera, ; Daidone, ; Maria, Grazia; Licitra, ; Lisa, F.; Locati, ; Laura, Deborah | |
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area | 1-gen-2017 | Cavallo, ; Cicchetti, ; Iacovelli, ; N., A.; Alessi, ; Padovano, ; Colombo, ; Facchinetti, ; Alfieri, ; Bossi, ; Resteghini, C; Licitra, ; Fallai, ; Crippa, ; Rancati, ; Pignoli, ; Orlandi, | |
Sinonasal non-glandular cancers relapsing after multimodal treatments | 1-gen-2017 | Cavalieri, ; Granata, ; Locati, ; L., D.; Bergamini, ; Alfieri, ; Resteghini, C; Galbiati, ; Orlandi, ; Iacovelli, ; N., A.; Calareso, ; Guzzo, ; Quattrone, ; Licitra, ; Bossi, | |
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial | 1-gen-2022 | Bossi, ; Paolo, ; Alberti, ; Andrea, ; Bergamini, ; Cristiana, ; Resteghini, C; Locati, ; Laura, Deborah; Alfieri, ; Salvatore, ; Cavalieri, ; Stefano, ; Colombo, ; Elena, ; Gurizzan, ; Cristina, ; Lorini, ; Luigi, ; Tovazzi, ; Valeria, ; Zamparini, ; Manuel, ; Ravanelli, ; Marco, ; Ascierto, ; Paolo, Antonio; Rampinelli, ; Vittorio, ; Grammatica, ; Alberto, ; Patuzzo, ; Roberto, ; Maurichi, ; Andrea, ; Licitra, ; Lisa, F. | |
Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration | 1-gen-2022 | Trama, ; Matsuda, ; Charvat, ; Chiang, ; R. R., C-J.; Van, Gestel; A., J.; Martin, ; Geleijnse, ; Bonfarnuzzo, ; Licitra, ; L., F.; Cavalieri, ; Resteghini, C; Gatta, ; Botta, | |
A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer | 1-gen-2017 | Cavalieri, ; Granata, ; Locati, ; Bergamini, ; Alfieri, ; Resteghini, C; Galbiati, ; Orlandi, ; Iacovelli, ; N., A.; Calareso, ; Guzzo, ; Quattrone, ; Licitra, ; Bossi, | |
An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients? | 1-gen-2016 | Cassini, ; Alfieri, ; Bossi, ; Bergamini, ; Granata, ; Resteghini, C; Galbiati, ; Iacovelli, ; N., A.; Orlandi, ; Favales, ; Villa, ; Pistillo, ; Locati, ; Licitra, | |
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) | 1-gen-2021 | Bossi, ; Resteghini, C; Orlandi, ; Nicolai, ; Vischioni, ; Castelnuovo, ; Turri-Zanoni, ; Ferrari, ; Rampelli, ; Facchinetti, ; Gambazza, ; Calareso, ; Quattrone, ; Ingargiola, ; Cavallo, ; Franceschini, ; Tuzi, ; Mariani, ; Licitra, ; L., F. | |
A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era | 1-gen-2022 | Bossi, ; Alberti, ; Zamparini, ; Orlandi, ; Grisanti, ; Trama, ; Resteghini, C; Nin, ; R., Mesia; Mohamad, ; Ozyar, ; Buglione, ; Airoldi, ; Vecchio, ; Livi, ; Cirauqui, ; B., Cirauqui; El-Sherify, ; Ursino, ; Argiris, ; Galiana, ; I., Linares; Licitra, ; L., F. | |
Druggable molecular targets in skin adnexal malignancies | 1-gen-2018 | Cavalieri, ; Stefano, ; Perrone, ; Federica, ; Quattrone, ; Pasquale, ; Locati, ; Laura, ; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Alfieri, ; Salvatore, ; Resteghini, C; Galbiati, ; Donata, ; Platini, ; Francesca, ; Calareso, ; Giuseppina, ; Licitra, ; Lisa, F.; Bossi, ; Paolo, | |
Transcriptomic and tumor microenvironment landscape of EBV related nasopharyngeal carcinoma in endemic and non-endemic areas | 1-gen-2022 | Licitra, ; L., F.; Serafini, ; Pistore, ; Canevari, ; Resteghini, C; Cavalieri, ; Trama, ; De, Cecco | |
Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies. | 1-gen-2019 | Resteghini, C; Cavalieri, ; Stefano, ; Rametta, ; Alessandro, ; Alfieri, ; Salvatore, ; Galbiati, ; Donata, ; Platini, ; Francesca, ; Locati, ; Laura, Deborah; Bossi, ; Paolo, ; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Orlandi, ; Ester, ; Piazza, ; Cesare, ; Mancinelli, ; Moela, ; Licitra, ; Lisa, F. | |
Phase II study on lenvatinib (LEN) in recurrent and/or metastatic (R/M) adenoid cystic carcinomas (ACC) of the salivary glands (SG) of the upper aereodigestive tract (NCT02860936) | 1-gen-2018 | Locati, ; Laura, ; Galbiati, ; Donata, ; Calareso, ; Giuseppina, ; Alfieri, ; Salvatore, ; Granata, ; Roberta, ; Bossi, ; Paolo, ; Bergamini, ; Cristiana, ; Resteghini, C; Cavalieri, ; Stefano, ; Platini, ; Francesca, ; Quattrone, ; Pasquale, ; Mancinelli, ; Moela, ; Zucchella, ; Andrea, ; Mariani, ; Luigi, ; Fedele, ; Guido, ; Licitra, ; Lisa, F. | |
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission | 1-gen-2021 | Alfieri, ; Marceglia, ; Filippini, ; D., M.; Bergamini, ; Resteghini, C; Cavalieri, ; Peris, ; Sollena, ; Piccerillo, ; Gualdi, ; Ascierto, ; P., A.; Curvietto, ; Palla, ; De, Giorgi; Eibenschutz, ; Spagnolo, ; Orlandi, ; Locati, ; L., D.; Licitra, ; L., F.; Bossi, | |
Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract | 1-gen-2019 | Locati, ; L., D.; Cavalieri, ; Bergamini, ; Resteghini, C; Alfieri, ; Calareso, ; Bossi, ; Quattrone, ; Granata, ; Galbiati, ; Platini, ; Orlandi, ; Mariani, ; Licitra, | |
Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience | 1-gen-2016 | Alfieri, ; Bossi, ; Granata, ; Bergamini, C; Resteghini, C; Galbiati, ; Locati, ; Licitra, | |
Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer | 1-gen-2019 | Bologna, ; Calareso, ; Resteghini, C; Sdao, ; Montin, ; Corino, ; Mainardi, ; Licitra, ; Bossi, | |
Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients | 1-gen-2020 | Ivaldi, ; Infante, ; Facchinetti, ; Bossi, ; Iacovelli, ; N., A.; Cavallo, ; Ingargiola, ; Locati, ; L., D.; Bergamini, ; Resteghini, C; Licitra, ; Platini, ; Calareso, ; Fallai, ; Orlandi, | |
RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted? | 1-gen-2016 | Resteghini, C; Alfieri, ; Quattrone, ; Dominoni, ; Garzone, ; Orlandi, ; Locati, ; Bergamini, ; Galbiati, ; Iacovelli, ; N., A.; Licitra, ; Bossi, | |
Relation between site of origin of monomorphic ventricular arrhythmias and myocardial tissue characteristics in non-ischemic left ventricular heart disease | 1-gen-2014 | Nucifora, G; Muser, D; Masci, Pg; Barison, A; Piccoli, G; Rebellato, L; Facchin, D; Daleffe, E; Lombardi, M; Proclemer, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1974
Data di pubblicazione
- 2020 - 202490
- 2010 - 20191238
- 2000 - 2009534
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY121
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...119
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE96
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY56
- ANNALS OF ONCOLOGY46
- HEPATOLOGY43
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng695
- ita24
- und6
Accesso al fulltext
- no fulltext1921
- reserved51
- open2